China Biologic Produ (CBPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 144,938 | 80,820 | 144,139 | 129,609 | 89,412 |
Marketable Securities | 38,033 | 63,678 | 6,609 | N/A | N/A |
Receivables | 25,145 | 19,403 | 17,270 | 11,206 | 16,757 |
Inventories | 126,395 | 101,305 | 88,635 | 75,679 | 71,339 |
Other current assets | 10,056 | 0 | 0 | 0 | 0 |
TOTAL | $369,113 | $279,987 | $264,293 | $222,160 | $183,694 |
Non-Current Assets | |||||
PPE Net | 105,364 | 80,231 | 73,149 | 51,325 | 43,330 |
Investments And Advances | 8,718 | 18,222 | 11,350 | 10,537 | 8,357 |
Intangibles | 23,576 | 11,909 | 8,213 | 9,360 | 12,008 |
Other Non-Current Assets | 44,695 | 56,498 | 46,776 | 17,665 | 1,505 |
TOTAL | $182,354 | $166,860 | $139,488 | $88,888 | $65,199 |
Total Assets | $551,467 | $446,847 | $403,781 | $311,047 | $248,893 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | N/A | 57,903 | 9,822 | 7,935 | 11,018 |
Accounts payable and accrued liabilities | 67,144 | 54,522 | 49,414 | 32,414 | 41,168 |
Other current liabilities | N/A | N/A | N/A | 2,857 | 10,263 |
TOTAL | $71,655 | $120,682 | $63,439 | $47,719 | $67,822 |
Non-Current Liabilities | |||||
Long Term Debt | N/A | 40,000 | 30,000 | N/A | N/A |
Other Non-Current Liabilities | -16,739 | -17,057 | -18,891 | -17,753 | -11,172 |
TOTAL | $12,849 | $50,904 | $36,373 | $5,909 | $2,029 |
Total Liabilities | $84,505 | $171,585 | $99,812 | $53,628 | $69,852 |
Shareholders' Equity | |||||
Shares Outstanding, K | 26,591 | 24,812 | 23,368 | 26,822 | 25,601 |
Common Shares | 3 | 3 | 3 | 3 | 3 |
Retained earnings | 333,704 | 244,661 | 173,745 | 119,143 | 73,921 |
Other shareholders' equity | 84,175 | 83,589 | 88,190 | 76,022 | 56,279 |
TOTAL | $466,962 | $275,262 | $303,970 | $257,419 | $179,041 |
Total Liabilities And Equity | $551,467 | $446,847 | $403,781 | $311,047 | $248,893 |